Waters moves into Malaysia to tap growing bioprocessing market

By Dan Stanton contact

- Last updated on GMT

photo - chelovek/iStock
photo - chelovek/iStock
Analytical and downstream technology firm Waters has opened a subsidiary in Malaysia, citing the steady and consistent growth of biopharma in the region as a driver.

The company said its new subsidiary, Waters and TA Instrument technologies located in Kuala Lumpar, will be more effective in supplying its product portfolio to the region, in light of “steady and consistent increases in demand,”​ according to spokesman Jeff Tarmy.

Tarmy told Biopharma-Reporter.com the subsidiary “will support the full line of chromatography, chemistries, detection and informatics solutions from Waters Division and the full line of thermal analysis. rheology and microcalorimetry solutions from TA Instruments.”

While Waters Corporation supplies a number of industries with analytical tools, mass spectrometry and separations science equipment, around 60% of its revenues comes from the life science sector.

These technologies are, and will be, supported for the full range of end markets, including biopharmaceutical applications.”

He added Waters has seen “dynamic development”​ in Malaysia and took the opportunity to “extend our support to our expanding customer base by establishing direct in-country operations.”

Malaysian growth

There has been a drive within Malaysia to increase its bioprocessing capabilities, with the Government launching a bio-hub located at a 160 acre park in Johor in 2013​. The Bio-XCell Biotechnology Park gives manufacturers the option to lease plots for production plants and easy access to utilities.

Indian biopharma firm Biocon too has invested in the country, building a RM 500m ($118m) insulin plant in Johor in 2011​.

The news comes following a strong year financially for Waters in Asia, according to CFO Gene Cassis.

He told delegates at the Stifel Health Care Conference last month (transcript here​) the firm has seen both recurring revenues and a strong growth rate in its Asian business.

“We've also begun to see that culturally paying for service is becoming much more understood and acceptable in some of our larger Asian markets.”

Related news

Show more

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Downstream Purification of Large Biomolecules

Downstream Purification of Large Biomolecules

Bio-Rad Laboratories | 17-Sep-2018 | Research Study

Our newest strong anion exchange resin provides both high binding capacity and
high recovery, even at high flow rates. A rigid bead complete with...

Related suppliers

Follow us

Products

View more

Webinars